Exploring skeletal muscle tolerance and whole‐body metabolic effects of FDA‐approved drugs in a volumetric muscle loss model

Exploring skeletal muscle tolerance and whole‐body metabolic effects of FDA‐approved drugs in a volumetric muscle loss model

Abstract Volumetric muscle loss (VML) is associated with persistent functional impairment due to a lack of de novo muscle regeneration. As mechanisms driving the lack of regeneration continue to be established, adjunctive pharmaceuticals to address the pathophysiology of the remaining muscle may off...

Full description

Bibliographic Details
Main Authors: Shefali R. Bijwadia, Christiana J. Raymond‐Pope, Alec M. Basten, Mason T. Lentz, Thomas J. Lillquist, Jarrod A. Call, Sarah M. Greising
Format: Article
Language:English
Published: Wiley 2023-06-01
Series:Physiological Reports
Subjects:
formoterol
muscle function
neuromusculoskeletal injury
nintedanib
skeletal muscle injury
Online Access:https://doi.org/10.14814/phy2.15756

Internet

https://doi.org/10.14814/phy2.15756

Similar Items